Knockdown of TLR4 by shRNA in glioma CD133+ CSCs inhibited LPS-stimulated CSC proliferation and reversed the inhibitory effect of LPS-induced glioma CD133+ CSCs on the cytotoxicity of CTLs. The gene discussed is PROM1; the disease is central nervous system cancer.